Brainsway Ltd..
Medical technology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 30
What's happening
Earlier this month
Gone quiet
No new reports in 90+ days-
Brainsway Ltd. requires FDA clearance for its Deep TMS protocol, tied to regional market growth in North America.Some support1 report
-
Brainsway Ltd. listed its American Depositary Receipts (ADRs) on the Nasdaq stock exchange. Harel Insurance Investments was also involved in a stake purchase.Some support13 reports
-
Brainsway Ltd. is expanding its policy coverage across the U.S. and gaining favorable policy coverage in South Carolina.Some support2 reports
-
Brainsway Ltd. and Boston Scientific operate in the medical device industry.Speculative1 report
-
Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.Some support2 reports
-
Brainsway Ltd. received upward earnings estimate revisions on August 19, 2025.Some support4 reports
-
BrainsWay invests in Axis Integrated Mental Health to expand access to care, following previous investments in Stella.Some support1 report
-
Brainsway Ltd. secured a strategic investment that is expected to expand its market reach.Some support2 reports
-
BrainsWay Ltd. provided a strategic investment to Neurolief, which is awaiting FDA approval for its drug Proliv™Rx.Some support1 report1 development inside
No events began in the chosen period. Widen it, or reset.
Around Brainsway Ltd. this week
News at the entities that move Brainsway Ltd. most-
FDA StructuralThe FDA's authorization decision sparked criticism from the American Lung Association, which was also involved in a public statement via Thomas Carr.Moves Brainsway Ltd.
-
SWIFT OperationalChainlink announced a partnership on September 7th with a top-three services provider.Moves Brainsway Ltd.
-
South Carolina StructuralDepartment of Education manages a scholarship trust fund program in South Carolina.Moves Brainsway Ltd.
-
MarketBeat Mentioned togetherGlobus Maritime Limited, which trades on Nasdaq, disclosed an acquisition and a director's share purchase via an SEC filing.Moves Brainsway Ltd.
-
Renaissance Technologies TransactionalRenaissance Technologies boosted its stake in the Direxion Daily FTSE China Bear 3X ETF, which was designed using a China Index created by Bank of New York.Moves Brainsway Ltd.
-
Royal Bank of Canada TransactionalMarketBeat reports consensus ratings from sixteen brokerages, including RBC's 'outperform' rating and Scotiabank's target price cut for Lightspeed.Moves Brainsway Ltd.
Connections
The 13 strongest of 30, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates Brainsway Ltd., granting it market indications and clearance for its treatment protocols.
-
Harel Insurance Investments & Financial Services Ltd. Transactional
Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Brainsway Ltd. in July 2026.
-
Nasdaq Structural
Brainsway Ltd. maintains a formal ADR listing on the Nasdaq stock exchange.
-
SEC Structural
Brainsway Ltd. must comply with the regulatory requirements and filing mandates of the SEC to operate.
-
SWIFT Operational
SWIFT's financial infrastructure facilitates the acceleration of Brainsway's Deep TMS protocol adoption.
-
Renaissance Technologies Transactional
Renaissance Technologies increased its investment stake in Brainsway Ltd. during Q1.
-
South Carolina Structural
Brainsway Ltd. is gaining favorable policy coverage and benefiting from the regulatory environment of South Carolina.
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its investment holdings in Brainsway Ltd.
Show all 13 connections
-
Burlington Shared context
Brainsway Ltd. operates and reports results from the location of Burlington.
-
MarketBeat Mentioned together
MarketBeat provides and hosts stock performance ratings and consensus recommendations for Brainsway Ltd.
-
Jerusalem Shared context
Brainsway Ltd. operates and reports financial results from Jerusalem.
-
North America Shared context
Brainsway Ltd.'s market growth is linked to the regional demand dynamics of North America.
-
TMS Mentioned together
The evidence describes TMS's operations but does not mention or describe any relationship with Brainsway Ltd.
History
Events by the month they beganOctober 2026
1 eventJuly 2026
2 eventsJune 2026
7 events- Brainsway Ltd. is expanding its policy coverage across the U.S. and gaining favorable policy coverage in South Carolina.
- Brainsway Ltd. and Boston Scientific operate in the medical device industry.
- Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.
- Brainsway Ltd. received upward earnings estimate revisions on August 19, 2025.
- BrainsWay invests in Axis Integrated Mental Health to expand access to care, following previous investments in Stella.
- Brainsway Ltd. secured a strategic investment that is expected to expand its market reach.
- BrainsWay Ltd. provided a strategic investment to Neurolief, which is awaiting FDA approval for its drug Proliv™Rx.